Author

Mathieu Perrée

Observed names: M Perree, M. Perree, Mathieu Perree

Observed institutions: Memorial Sloan Kettering Cancer Center, East Carolina University, Yale Cancer Center, Tennessee Oncology, Nashville Oncology Associates, Concordia University

OpenAlex ID: A5067066172

The Microculture-Kinetic (MiCK) Assay: The Role of a Drug-Induced Apoptosis Assay in Drug Development and Clinical Care

2012 · Linda Bosserman, Franklyn Prendergast, et al. · Cancer Research · 19

Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment

2010 · Karen S. Ballard, Howard D. Homesley, et al. · Journal of Gynecologic Oncology · 15

Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response

2012 · Emery Salom, Manuel Penalver, et al. · Journal of Translational Medicine · 14

Application of a Drug-Induced Apoptosis Assay to Identify Treatment Strategies in Recurrent or Metastatic Breast Cancer

2015 · Linda Bosserman, Karl Rogers, et al. · PLoS ONE · 12

Correlation of the microculture-kinetic drug-induced apoptosis assay with patient outcomes in initial treatment of adult acute myelocytic leukemia

2012 · Stephen A. Strickland, Anastasios Raptis, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 11

The value of personalized treatment (Rx) planning (PTP): Cost savings (sav) by the Microculture Kinetic (MiCK) chemosensitivity (CS) assay, evidence from a large American self-insured company (ASIC)

2009 · R. G. Latimer, C. A. Presant, et al. · Journal of Clinical Oncology · 6

Chemosensitivity (CS) of patient (pt) breast cancer (BrCa) cells in vitro: Correlation with prior chemotherapy (CT) and implications for personalized treatment planning

2009 · P. W. Whitworth, C. A. Presant, et al. · Journal of Clinical Oncology · 5

Can we increase response rate (RR) and overall survival (OS) by individualizing chemotherapy in ovarian cancer (OC): The role of a new chemotherapy (CT) induced apoptosis assay.

2010 · E. M. Salom, M. Penalver, et al. · Journal of Clinical Oncology · 4

Inhibition of MIF with an Allosteric Inhibitor Triggers Cell Cycle Arrest in Acute Myeloid Leukemia

2025 · Georgios Pantouris, Leepakshi Khurana, et al. · ACS Omega · 3

Endometrial carcinoma in-vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic (MICK) apoptosis assay: Implications for endometrial cancer treatment

2010 · K. Ballard, H. Homesley, et al. · Gynecologic Oncology · 2

Tumor heterogeneity revealed by drug-induced apoptosis (MiCK) assays in lung cancer.

2014 · Dennis A. Wigle, Cary A. Presant, et al. · Journal of Clinical Oncology

Drug-induced apoptosis in mesothelioma cells from chemotherapy-naive versus patients receiving prior chemotherapy.

2014 · Julian R. Molina, Cary A. Presant, et al. · Journal of Clinical Oncology

Abstract P3-06-28: Use of the MiCK drug-induced apoptosis assay improves clinical outcomes in recurrent breast cancer (BRCA)

2012 · L Bosserman, K Rogers, et al. · Cancer Research

Expression de récepteurs Ly49 inhibiteurs par différentes populations leucocytaires.

2003 · Mathieu Perrée · EspaceINRS (National Institute for Scientific Research (Canada))

Works count: 14

Citation count: 91

H-index: 6

I10-index: 5